Price List Femlyv - Contraceptive Agents - Multiple.xlsx
XLSX spreadsheet 46 KB Posted
- Solicitation number
- HT9402-24-Q-9404
- Issued by
-
Defense Health Agency
About this file
This document is a Price List and Blanket Purchase Agreement Appendix related to a Department of Defense (DoD) Uniform Formulary contract opportunity for Contraceptive Agents. The DoD Pharmacy and Therapeutics Committee will review newly approved drugs, including Femlyv, at their November 2024 meeting. The DoD is seeking quotes from industry for the placement of these drugs on the Uniform Formulary, including pricing, discount, and refund information. Quotes are due by October 16, 2024, and the DoD may award Uniform Formulary Blanket Purchase Agreements and Additional Discount Program Agreements based on the Uniform Formulary decisions. The document provides pricing templates for 10 newly approved Contraceptive Agent drugs across various formulary scenarios, package sizes, and pricing models including Federal Ceiling Price and Wholesale Acquisition Cost discounts.
View the file
Other files
| File | Type | Posted |
|---|---|---|
| Price List - Aqneursa - Neurological Agents Misc - NA.xlsx | XLSX spreadsheet | |
| Amendment 0001.pdf | ||
| Price List - Cobenfy - Antipsychotic Agents - Atypical.xlsx | XLSX spreadsheet | |
| Price List Onyda XR - ADHD Agents - Non-Stimulants.xlsx | XLSX spreadsheet | |
| RFQ HT9402-24-Q-9404 NAD.pdf | ||
| Price Appendix FAQ NAD.pdf | ||
| Price List Lazcluze - Oncological Agents - Multiple.xlsx | XLSX spreadsheet | |
| Price List Ebglyss - ATOPY - NA.xlsx | XLSX spreadsheet | |
| Price List Yorvipath - Osteoporosis Agents - PTH Analogs.xlsx | XLSX spreadsheet | |
| DoD Formulary Placement of FDA Newly Approved Drugs.pdf | ||
| Price List Clobetasol Propionate - Ophthalmic - Corticosteroids.xlsx | XLSX spreadsheet | |
| Price List Tryvio - Antihypertensive Agents - Endothelin Receptor Antagonists.xlsx | XLSX spreadsheet |
Show all 12
On GovTribe
Work with this file
- Download the original file
- Contacts named in this file
- Similar government files
- Ask GovTribe AI about this file
Text version
BPA
| UF BPA NDC Price List for the November 2024 DoD P&T Meeting | |||
| DOD Uniform Formulary Class: | CONTRACEPTIVE AGENTS | P&T Committee Meeting: | November 6-7, 2024 |
| DOD Uniform Formulary Subclass: | MULTIPLE | Quotes due: | October 16, 2024 |
| Formulary Notes | |||
| Class Note(s): Prior Authorization may apply. |
Step Therapy Addendum: N/A
Notes to Manufacturers: Do not forget to submit fully executed signature pages along with quote information.
The price per unit of measure for a given dosage form and strength (each, gram, mL, etc.) of the pharmaceutical agent will be the same for all available package sizes (e.g., 30s, 100s, 1000s) within a given dispensing venue.
Blanket Purchase Agreement Appendix – Newly Approved Drug
| #1 | DOD Uniform Formulary Class: | CONTRACEPTIVE AGENTS | P&T Committee Meeting: | November 6-7, 2024 | ||
| DOD Uniform Formulary Subclass: | MULTIPLE | Quotes due: | October 16, 2024 | |||
| NDC Number | Drug Name | Strength | Dosage Form | Package Size | Military Treatment Facility & Mail Order |
Formulary Scenarios Condition Set # Formulary Category Description One of (x) Number of Brand Agents Price per NDC Package Size Price per Unit
| Scenario 1 | 162OCMUN0UFNS1M | Uniform Formulary | |||
| No Step Therapy | 1 or more | NO QUOTE | |||
| 162OCMUN0NFNS1M | Non-Formulary | ||||
| No Step Therapy | 1 or more | NO QUOTE | |||
| If cell highlights red, please confirm intent not to submit a quote |
Blanket Purchase Agreement Appendix – Newly Approved Drug
| #2 | DOD Uniform Formulary Class: | CONTRACEPTIVE AGENTS | P&T Committee Meeting: | November 6-7, 2024 | ||
| DOD Uniform Formulary Subclass: | MULTIPLE | Quotes due: | October 16, 2024 | |||
| NDC Number | Drug Name | Strength | Dosage Form | Package Size | Military Treatment Facility & Mail Order |
Formulary Scenarios Condition Set # Formulary Category Description One of (x) Number of Brand Agents Price per NDC Package Size Price per Unit
| Scenario 1 | 162OCMUN0UFNS1M | Uniform Formulary | |||
| No Step Therapy | 1 or more | NO QUOTE | |||
| 162OCMUN0NFNS1M | Non-Formulary | ||||
| No Step Therapy | 1 or more | NO QUOTE | |||
| If cell highlights red, please confirm intent not to submit a quote | |||||
| Blanket Purchase Agreement Appendix – Newly Approved Drug |
| #3 | DOD Uniform Formulary Class: | CONTRACEPTIVE AGENTS | P&T Committee Meeting: | November 6-7, 2024 | ||
| DOD Uniform Formulary Subclass: | MULTIPLE | Quotes due: | October 16, 2024 | |||
| NDC Number | Drug Name | Strength | Dosage Form | Package Size | Military Treatment Facility & Mail Order |
Formulary Scenarios Condition Set # Formulary Category Description One of (x) Number of Brand Agents Price per NDC Package Size Price per Unit
| Scenario 1 | 162OCMUN0UFNS1M | Uniform Formulary | |||
| No Step Therapy | 1 or more | NO QUOTE | |||
| 162OCMUN0NFNS1M | Non-Formulary | ||||
| No Step Therapy | 1 or more | NO QUOTE | |||
| If cell highlights red, please confirm intent not to submit a quote |
Blanket Purchase Agreement Appendix – Newly Approved Drug
| #4 | DOD Uniform Formulary Class: | CONTRACEPTIVE AGENTS | P&T Committee Meeting: | November 6-7, 2024 | ||
| DOD Uniform Formulary Subclass: | MULTIPLE | Quotes due: | October 16, 2024 | |||
| NDC Number | Drug Name | Strength | Dosage Form | Package Size | Military Treatment Facility & Mail Order |
Formulary Scenarios Condition Set # Formulary Category Description One of (x) Number of Brand Agents Price per NDC Package Size Price per Unit
| Scenario 1 | 162OCMUN0UFNS1M | Uniform Formulary | |||
| No Step Therapy | 1 or more | NO QUOTE | |||
| 162OCMUN0NFNS1M | Non-Formulary | ||||
| No Step Therapy | 1 or more | NO QUOTE | |||
| If cell highlights red, please confirm intent not to submit a quote | |||||
| Blanket Purchase Agreement Appendix – Newly Approved Drug |
| #5 | DOD Uniform Formulary Class: | CONTRACEPTIVE AGENTS | P&T Committee Meeting: | November 6-7, 2024 | ||
| DOD Uniform Formulary Subclass: | MULTIPLE | Quotes due: | October 16, 2024 | |||
| NDC Number | Drug Name | Strength | Dosage Form | Package Size | Military Treatment Facility & Mail Order |
Formulary Scenarios Condition Set # Formulary Category Description One of (x) Number of Brand Agents Price per NDC Package Size Price per Unit
| Scenario 1 | 162OCMUN0UFNS1M | Uniform Formulary | |||
| No Step Therapy | 1 or more | NO QUOTE | |||
| 162OCMUN0NFNS1M | Non-Formulary | ||||
| No Step Therapy | 1 or more | NO QUOTE | |||
| If cell highlights red, please confirm intent not to submit a quote |
Blanket Purchase Agreement Appendix – Newly Approved Drug
| #6 | DOD Uniform Formulary Class: | CONTRACEPTIVE AGENTS | P&T Committee Meeting: | November 6-7, 2024 | ||
| DOD Uniform Formulary Subclass: | MULTIPLE | Quotes due: | October 16, 2024 | |||
| NDC Number | Drug Name | Strength | Dosage Form | Package Size | Military Treatment Facility & Mail Order |
Formulary Scenarios Condition Set # Formulary Category Description One of (x) Number of Brand Agents Price per NDC Package Size Price per Unit
| Scenario 1 | 162OCMUN0UFNS1M | Uniform Formulary | |||
| No Step Therapy | 1 or more | NO QUOTE | |||
| 162OCMUN0NFNS1M | Non-Formulary | ||||
| No Step Therapy | 1 or more | NO QUOTE | |||
| If cell highlights red, please confirm intent not to submit a quote |
Blanket Purchase Agreement Appendix – Newly Approved Drug
| #7 | DOD Uniform Formulary Class: | CONTRACEPTIVE AGENTS | P&T Committee Meeting: | November 6-7, 2024 | ||
| DOD Uniform Formulary Subclass: | MULTIPLE | Quotes due: | October 16, 2024 | |||
| NDC Number | Drug Name | Strength | Dosage Form | Package Size | Military Treatment Facility & Mail Order |
Formulary Scenarios Condition Set # Formulary Category Description One of (x) Number of Brand Agents Price per NDC Package Size Price per Unit
| Scenario 1 | 162OCMUN0UFNS1M | Uniform Formulary | |||
| No Step Therapy | 1 or more | NO QUOTE | |||
| 162OCMUN0NFNS1M | Non-Formulary | ||||
| No Step Therapy | 1 or more | NO QUOTE | |||
| If cell highlights red, please confirm intent not to submit a quote |
Blanket Purchase Agreement Appendix – Newly Approved Drug
| #8 | DOD Uniform Formulary Class: | CONTRACEPTIVE AGENTS | P&T Committee Meeting: | November 6-7, 2024 | ||
| DOD Uniform Formulary Subclass: | MULTIPLE | Quotes due: | October 16, 2024 | |||
| NDC Number | Drug Name | Strength | Dosage Form | Package Size | Military Treatment Facility & Mail Order |
Formulary Scenarios Condition Set # Formulary Category Description One of (x) Number of Brand Agents Price per NDC Package Size Price per Unit
| Scenario 1 | 162OCMUN0UFNS1M | Uniform Formulary | |||
| No Step Therapy | 1 or more | NO QUOTE | |||
| 162OCMUN0NFNS1M | Non-Formulary | ||||
| No Step Therapy | 1 or more | NO QUOTE | |||
| If cell highlights red, please confirm intent not to submit a quote | |||||
| Blanket Purchase Agreement Appendix – Newly Approved Drug |
| #9 | DOD Uniform Formulary Class: | CONTRACEPTIVE AGENTS | P&T Committee Meeting: | November 6-7, 2024 | ||
| DOD Uniform Formulary Subclass: | MULTIPLE | Quotes due: | October 16, 2024 | |||
| NDC Number | Drug Name | Strength | Dosage Form | Package Size | Military Treatment Facility & Mail Order |
Formulary Scenarios Condition Set # Formulary Category Description One of (x) Number of Brand Agents Price per NDC Package Size Price per Unit
| Scenario 1 | 162OCMUN0UFNS1M | Uniform Formulary | |||
| No Step Therapy | 1 or more | NO QUOTE | |||
| 162OCMUN0NFNS1M | Non-Formulary | ||||
| No Step Therapy | 1 or more | NO QUOTE | |||
| If cell highlights red, please confirm intent not to submit a quote | |||||
| Blanket Purchase Agreement Appendix – Newly Approved Drug |
| #10 | DOD Uniform Formulary Class: | CONTRACEPTIVE AGENTS | P&T Committee Meeting: | November 6-7, 2024 | ||
| DOD Uniform Formulary Subclass: | MULTIPLE | Quotes due: | October 16, 2024 | |||
| NDC Number | Drug Name | Strength | Dosage Form | Package Size | Military Treatment Facility & Mail Order |
Formulary Scenarios Condition Set # Formulary Category Description One of (x) Number of Brand Agents Price per NDC Package Size Price per Unit
| Scenario 1 | 162OCMUN0UFNS1M | Uniform Formulary | |||
| No Step Therapy | 1 or more | NO QUOTE | |||
| 162OCMUN0NFNS1M | Non-Formulary | ||||
| No Step Therapy | 1 or more | NO QUOTE | |||
| If cell highlights red, please confirm intent not to submit a quote |
ADP (non-FAMP Discount)
| UF ADP Appendix for the November 2024 DoD P&T Meeting | |||
| DOD Uniform Formulary Class: | CONTRACEPTIVE AGENTS | P&T Committee Meeting: | November 6-7, 2024 |
| DOD Uniform Formulary Subclass: | MULTIPLE | Quotes due: | October 16, 2024 |
| Formulary Notes | |||
| Class Note(s): Prior Authorization may apply. |
Notes to Manufacturers: Do not forget to submit fully executed signature pages along with quote information.
* Total Calculated Refund Per FCP is calculated as: ((non-FAMP-FCP)+(non-FAMP*Y%)) = Total Calculated Refund **Based on the most recent annual non-FAMP (reported to the Department of Veterans Affairs) from which the current annual Federal Ceiling Price (FCP) calculated ceiling is derived. The current annual FCP and the annual non-FAMP from which it is derived will be applicable to all prescriptions filled during a calendar year. The quoted additional refund percentage will remain static during the life of the agreement but the most recent annual non-FAMP, and thus the calculated refund, may change each calendar year.
Additional Discount Program Appendix – Newly Approved Drug
| #1 | DOD Uniform Formulary Class: | CONTRACEPTIVE AGENTS | P&T Committee Meeting: | November 6-7, 2024 | |||
| DOD Uniform Formulary Subclass: | MULTIPLE | Quotes due: | October 16, 2024 | ||||
| NDC Number | Drug Name | Strength | Dosage Form | Package Size | TRICARE RETAIL REFUND |
Formulary Scenarios Condition Set # Formulary Category Description One of (x) Number of Brand Agents Non-FAMP Price of Drug Per FCP Package** Additional Offered Refund Per FCP Package** Current Annual Federal Ceiling Price Per FCP Package** Standard Refund Per FCP Total Calculated Retail Refund Per FCP Package*
| Scenario 1 | 162OCMUN0T2NS1M | Tier 2 | |||
| No Step Therapy | 1 or more | ||||
| 162OCMUN0T3NS1M | Tier 3 | ||||
| No Step Therapy | 1 or more | ||||
| If cell highlights red, please confirm intent not to submit a quote |
Additional Discount Program Appendix – Newly Approved Drug
| #2 | DOD Uniform Formulary Class: | CONTRACEPTIVE AGENTS | P&T Committee Meeting: | November 6-7, 2024 | |||
| DOD Uniform Formulary Subclass: | MULTIPLE | Quotes due: | October 16, 2024 | ||||
| NDC Number | Drug Name | Strength | Dosage Form | Package Size | TRICARE RETAIL REFUND |
Formulary Scenarios Condition Set # Formulary Category Description One of (x) Number of Brand Agents Non-FAMP Price of Drug Per FCP Package** Additional Offered Refund Per FCP Package** Current Annual Federal Ceiling Price Per FCP Package** Standard Refund Per FCP Total Calculated Retail Refund Per FCP Package*
| Scenario 1 | 162OCMUN0T2NS1M | Tier 2 | |||
| No Step Therapy | 1 or more | ||||
| 162OCMUN0T3NS1M | Tier 3 | ||||
| No Step Therapy | 1 or more | ||||
| If cell highlights red, please confirm intent not to submit a quote |
Additional Discount Program Appendix – Newly Approved Drug
| #3 | DOD Uniform Formulary Class: | CONTRACEPTIVE AGENTS | P&T Committee Meeting: | November 6-7, 2024 | |||
| DOD Uniform Formulary Subclass: | MULTIPLE | Quotes due: | October 16, 2024 | ||||
| NDC Number | Drug Name | Strength | Dosage Form | Package Size | TRICARE RETAIL REFUND |
Formulary Scenarios Condition Set # Formulary Category Description One of (x) Number of Brand Agents Non-FAMP Price of Drug Per FCP Package** Additional Offered Refund Per FCP Package** Current Annual Federal Ceiling Price Per FCP Package** Standard Refund Per FCP Total Calculated Retail Refund Per FCP Package*
| Scenario 1 | 162OCMUN0T2NS1M | Tier 2 | |||
| No Step Therapy | 1 or more | ||||
| 162OCMUN0T3NS1M | Tier 3 | ||||
| No Step Therapy | 1 or more | ||||
| If cell highlights red, please confirm intent not to submit a quote |
Additional Discount Program Appendix – Newly Approved Drug
| #4 | DOD Uniform Formulary Class: | CONTRACEPTIVE AGENTS | P&T Committee Meeting: | November 6-7, 2024 | |||
| DOD Uniform Formulary Subclass: | MULTIPLE | Quotes due: | October 16, 2024 | ||||
| NDC Number | Drug Name | Strength | Dosage Form | Package Size | TRICARE RETAIL REFUND |
Formulary Scenarios Condition Set # Formulary Category Description One of (x) Number of Brand Agents Non-FAMP Price of Drug Per FCP Package** Additional Offered Refund Per FCP Package** Current Annual Federal Ceiling Price Per FCP Package** Standard Refund Per FCP Total Calculated Retail Refund Per FCP Package*
| Scenario 1 | 162OCMUN0T2NS1M | Tier 2 | |||
| No Step Therapy | 1 or more | ||||
| 162OCMUN0T3NS1M | Tier 3 | ||||
| No Step Therapy | 1 or more | ||||
| If cell highlights red, please confirm intent not to submit a quote |
Additional Discount Program Appendix – Newly Approved Drug
| #5 | DOD Uniform Formulary Class: | CONTRACEPTIVE AGENTS | P&T Committee Meeting: | November 6-7, 2024 | |||
| DOD Uniform Formulary Subclass: | MULTIPLE | Quotes due: | October 16, 2024 | ||||
| NDC Number | Drug Name | Strength | Dosage Form | Package Size | TRICARE RETAIL REFUND |
Formulary Scenarios Condition Set # Formulary Category Description One of (x) Number of Brand Agents Non-FAMP Price of Drug Per FCP Package** Additional Offered Refund Per FCP Package** Current Annual Federal Ceiling Price Per FCP Package** Standard Refund Per FCP Total Calculated Retail Refund Per FCP Package*
| Scenario 1 | 162OCMUN0T2NS1M | Tier 2 | |||
| No Step Therapy | 1 or more | ||||
| 162OCMUN0T3NS1M | Tier 3 | ||||
| No Step Therapy | 1 or more | ||||
| If cell highlights red, please confirm intent not to submit a quote |
Additional Discount Program Appendix – Newly Approved Drug
| #6 | DOD Uniform Formulary Class: | CONTRACEPTIVE AGENTS | P&T Committee Meeting: | November 6-7, 2024 | |||
| DOD Uniform Formulary Subclass: | MULTIPLE | Quotes due: | October 16, 2024 | ||||
| NDC Number | Drug Name | Strength | Dosage Form | Package Size | TRICARE RETAIL REFUND |
Formulary Scenarios Condition Set # Formulary Category Description One of (x) Number of Brand Agents Non-FAMP Price of Drug Per FCP Package** Additional Offered Refund Per FCP Package** Current Annual Federal Ceiling Price Per FCP Package** Standard Refund Per FCP Total Calculated Retail Refund Per FCP Package*
| Scenario 1 | 162OCMUN0T2NS1M | Tier 2 | |||
| No Step Therapy | 1 or more | ||||
| 162OCMUN0T3NS1M | Tier 3 | ||||
| No Step Therapy | 1 or more | ||||
| If cell highlights red, please confirm intent not to submit a quote |
Additional Discount Program Appendix – Newly Approved Drug
| #7 | DOD Uniform Formulary Class: | CONTRACEPTIVE AGENTS | P&T Committee Meeting: | November 6-7, 2024 | |||
| DOD Uniform Formulary Subclass: | MULTIPLE | Quotes due: | October 16, 2024 | ||||
| NDC Number | Drug Name | Strength | Dosage Form | Package Size | TRICARE RETAIL REFUND |
Formulary Scenarios Condition Set # Formulary Category Description One of (x) Number of Brand Agents Non-FAMP Price of Drug Per FCP Package** Additional Offered Refund Per FCP Package** Current Annual Federal Ceiling Price Per FCP Package** Standard Refund Per FCP Total Calculated Retail Refund Per FCP Package*
| Scenario 1 | 162OCMUN0T2NS1M | Tier 2 | |||
| No Step Therapy | 1 or more | ||||
| 162OCMUN0T3NS1M | Tier 3 | ||||
| No Step Therapy | 1 or more | ||||
| If cell highlights red, please confirm intent not to submit a quote |
Additional Discount Program Appendix – Newly Approved Drug
| #8 | DOD Uniform Formulary Class: | CONTRACEPTIVE AGENTS | P&T Committee Meeting: | November 6-7, 2024 | |||
| DOD Uniform Formulary Subclass: | MULTIPLE | Quotes due: | October 16, 2024 | ||||
| NDC Number | Drug Name | Strength | Dosage Form | Package Size | TRICARE RETAIL REFUND |
Formulary Scenarios Condition Set # Formulary Category Description One of (x) Number of Brand Agents Non-FAMP Price of Drug Per FCP Package** Additional Offered Refund Per FCP Package** Current Annual Federal Ceiling Price Per FCP Package** Standard Refund Per FCP Total Calculated Retail Refund Per FCP Package*
| Scenario 1 | 162OCMUN0T2NS1M | Tier 2 | |||
| No Step Therapy | 1 or more | ||||
| 162OCMUN0T3NS1M | Tier 3 | ||||
| No Step Therapy | 1 or more | ||||
| If cell highlights red, please confirm intent not to submit a quote |
Additional Discount Program Appendix – Newly Approved Drug
| #9 | DOD Uniform Formulary Class: | CONTRACEPTIVE AGENTS | P&T Committee Meeting: | November 6-7, 2024 | |||
| DOD Uniform Formulary Subclass: | MULTIPLE | Quotes due: | October 16, 2024 | ||||
| NDC Number | Drug Name | Strength | Dosage Form | Package Size | TRICARE RETAIL REFUND |
Formulary Scenarios Condition Set # Formulary Category Description One of (x) Number of Brand Agents Non-FAMP Price of Drug Per FCP Package** Additional Offered Refund Per FCP Package** Current Annual Federal Ceiling Price Per FCP Package** Standard Refund Per FCP Total Calculated Retail Refund Per FCP Package*
| Scenario 1 | 162OCMUN0T2NS1M | Tier 2 | |||
| No Step Therapy | 1 or more | ||||
| 162OCMUN0T3NS1M | Tier 3 | ||||
| No Step Therapy | 1 or more | ||||
| If cell highlights red, please confirm intent not to submit a quote |
Additional Discount Program Appendix – Newly Approved Drug
| #10 | DOD Uniform Formulary Class: | CONTRACEPTIVE AGENTS | P&T Committee Meeting: | November 6-7, 2024 | |||
| DOD Uniform Formulary Subclass: | MULTIPLE | Quotes due: | October 16, 2024 | ||||
| NDC Number | Drug Name | Strength | Dosage Form | Package Size | TRICARE RETAIL REFUND |
Formulary Scenarios Condition Set # Formulary Category Description One of (x) Number of Brand Agents Non-FAMP Price of Drug Per FCP Package** Additional Offered Refund Per FCP Package** Current Annual Federal Ceiling Price Per FCP Package** Standard Refund Per FCP Total Calculated Retail Refund Per FCP Package*
| Scenario 1 | 162OCMUN0T2NS1M | Tier 2 | |||
| No Step Therapy | 1 or more | ||||
| 162OCMUN0T3NS1M | Tier 3 | ||||
| No Step Therapy | 1 or more | ||||
| If cell highlights red, please confirm intent not to submit a quote |
ADP (WAC Discount)
| UF ADP Appendix for the November 2024 DoD P&T Meeting | |||
| DOD Uniform Formulary Class: | CONTRACEPTIVE AGENTS | P&T Committee Meeting: | November 6-7, 2024 |
| DOD Uniform Formulary Subclass: | MULTIPLE | Quotes due: | October 16, 2024 |
| Formulary Notes | |||
| Class Note(s): Prior Authorization may apply. |
Notes to Manufacturers: Do not forget to submit fully executed signature pages along with quote information.
The Wholesale Acquisition Cost (WAC) is obtained from First Databank via daily price updates; it is maintained at the dispensing unit level to five (5) decimal places. If the WAC changes during a calendar quarter, an average WAC will be calculated on a daily weighted basis (per unit only).
WAC is ONLY used for products that do not have a FCP, such as diabetic supplies (i.e., test strips), and can also be applied to covered drugs.
*The quoted WAC Discount percentage will remain static during the life of the agreement.
Additional Discount Program Appendix – Newly Approved Drug
| #1 | DOD Uniform Formulary Class: | CONTRACEPTIVE AGENTS | P&T Committee Meeting: | November 6-7, 2024 | ||
| DOD Uniform Formulary Subclass: | MULTIPLE | Quotes due: | October 16, 2024 | |||
| NDC Number | Drug Name | Strength | Dosage Form | Package Size | TRICARE RETAIL REFUND |
Formulary Scenarios Condition Set # Formulary Category One of (x) Number of Brand Agents WAC Price of Drug WAC Discount* Total Calculated Retail Refund per Package
| Scenario 1 | 162OCMUN0T2NS1M | Tier 2 | |||
| No Step Therapy | 1 or more | ||||
| 162OCMUN0T3NS1M | Tier 3 | ||||
| No Step Therapy | 1 or more | ||||
| If cell highlights red, please confirm intent not to submit a quote |
Additional Discount Program Appendix – Newly Approved Drug
| #2 | DOD Uniform Formulary Class: | CONTRACEPTIVE AGENTS | P&T Committee Meeting: | November 6-7, 2024 | ||
| DOD Uniform Formulary Subclass: | MULTIPLE | Quotes due: | October 16, 2024 | |||
| NDC Number | Drug Name | Strength | Dosage Form | Package Size | TRICARE RETAIL REFUND |
Formulary Scenarios Condition Set # Formulary Category One of (x) Number of Brand Agents WAC Price of Drug WAC Discount* Total Calculated Retail Refund per Package
| Scenario 1 | 162OCMUN0T2NS1M | Tier 2 | |||
| No Step Therapy | 1 or more | ||||
| 162OCMUN0T3NS1M | Tier 3 | ||||
| No Step Therapy | 1 or more | ||||
| If cell highlights red, please confirm intent not to submit a quote |
Additional Discount Program Appendix – Newly Approved Drug
| #3 | DOD Uniform Formulary Class: | CONTRACEPTIVE AGENTS | P&T Committee Meeting: | November 6-7, 2024 | ||
| DOD Uniform Formulary Subclass: | MULTIPLE | Quotes due: | October 16, 2024 | |||
| NDC Number | Drug Name | Strength | Dosage Form | Package Size | TRICARE RETAIL REFUND |
Formulary Scenarios Condition Set # Formulary Category One of (x) Number of Brand Agents WAC Price of Drug WAC Discount* Total Calculated Retail Refund per Package
| Scenario 1 | 162OCMUN0T2NS1M | Tier 2 | |||
| No Step Therapy | 1 or more | ||||
| 162OCMUN0T3NS1M | Tier 3 | ||||
| No Step Therapy | 1 or more | ||||
| If cell highlights red, please confirm intent not to submit a quote |
Additional Discount Program Appendix – Newly Approved Drug
| #4 | DOD Uniform Formulary Class: | CONTRACEPTIVE AGENTS | P&T Committee Meeting: | November 6-7, 2024 | ||
| DOD Uniform Formulary Subclass: | MULTIPLE | Quotes due: | October 16, 2024 | |||
| NDC Number | Drug Name | Strength | Dosage Form | Package Size | TRICARE RETAIL REFUND |
Formulary Scenarios Condition Set # Formulary Category One of (x) Number of Brand Agents WAC Price of Drug WAC Discount* Total Calculated Retail Refund per Package
| Scenario 1 | 162OCMUN0T2NS1M | Tier 2 | |||
| No Step Therapy | 1 or more | ||||
| 162OCMUN0T3NS1M | Tier 3 | ||||
| No Step Therapy | 1 or more | ||||
| If cell highlights red, please confirm intent not to submit a quote |
Additional Discount Program Appendix – Newly Approved Drug
| #5 | DOD Uniform Formulary Class: | CONTRACEPTIVE AGENTS | P&T Committee Meeting: | November 6-7, 2024 | ||
| DOD Uniform Formulary Subclass: | MULTIPLE | Quotes due: | October 16, 2024 | |||
| NDC Number | Drug Name | Strength | Dosage Form | Package Size | TRICARE RETAIL REFUND |
Formulary Scenarios Condition Set # Formulary Category One of (x) Number of Brand Agents WAC Price of Drug WAC Discount* Total Calculated Retail Refund per Package
| Scenario 1 | 162OCMUN0T2NS1M | Tier 2 | |||
| No Step Therapy | 1 or more | ||||
| 162OCMUN0T3NS1M | Tier 3 | ||||
| No Step Therapy | 1 or more | ||||
| If cell highlights red, please confirm intent not to submit a quote |
Additional Discount Program Appendix – Newly Approved Drug
| #6 | DOD Uniform Formulary Class: | CONTRACEPTIVE AGENTS | P&T Committee Meeting: | November 6-7, 2024 | ||
| DOD Uniform Formulary Subclass: | MULTIPLE | Quotes due: | October 16, 2024 | |||
| NDC Number | Drug Name | Strength | Dosage Form | Package Size | TRICARE RETAIL REFUND |
Formulary Scenarios Condition Set # Formulary Category One of (x) Number of Brand Agents WAC Price of Drug WAC Discount* Total Calculated Retail Refund per Package
| Scenario 1 | 162OCMUN0T2NS1M | Tier 2 | |||
| No Step Therapy | 1 or more | ||||
| 162OCMUN0T3NS1M | Tier 3 | ||||
| No Step Therapy | 1 or more | ||||
| If cell highlights red, please confirm intent not to submit a quote |
Additional Discount Program Appendix – Newly Approved Drug
| #7 | DOD Uniform Formulary Class: | CONTRACEPTIVE AGENTS | P&T Committee Meeting: | November 6-7, 2024 | ||
| DOD Uniform Formulary Subclass: | MULTIPLE | Quotes due: | October 16, 2024 | |||
| NDC Number | Drug Name | Strength | Dosage Form | Package Size | TRICARE RETAIL REFUND |
Formulary Scenarios Condition Set # Formulary Category One of (x) Number of Brand Agents WAC Price of Drug WAC Discount* Total Calculated Retail Refund per Package
| Scenario 1 | 162OCMUN0T2NS1M | Tier 2 | |||
| No Step Therapy | 1 or more | ||||
| 162OCMUN0T3NS1M | Tier 3 | ||||
| No Step Therapy | 1 or more | ||||
| If cell highlights red, please confirm intent not to submit a quote |
Additional Discount Program Appendix – Newly Approved Drug
| #8 | DOD Uniform Formulary Class: | CONTRACEPTIVE AGENTS | P&T Committee Meeting: | November 6-7, 2024 | ||
| DOD Uniform Formulary Subclass: | MULTIPLE | Quotes due: | October 16, 2024 | |||
| NDC Number | Drug Name | Strength | Dosage Form | Package Size | TRICARE RETAIL REFUND |
Formulary Scenarios Condition Set # Formulary Category One of (x) Number of Brand Agents WAC Price of Drug WAC Discount* Total Calculated Retail Refund per Package
| Scenario 1 | 162OCMUN0T2NS1M | Tier 2 | |||
| No Step Therapy | 1 or more | ||||
| 162OCMUN0T3NS1M | Tier 3 | ||||
| No Step Therapy | 1 or more | ||||
| If cell highlights red, please confirm intent not to submit a quote |
Additional Discount Program Appendix – Newly Approved Drug
| #9 | DOD Uniform Formulary Class: | CONTRACEPTIVE AGENTS | P&T Committee Meeting: | November 6-7, 2024 | ||
| DOD Uniform Formulary Subclass: | MULTIPLE | Quotes due: | October 16, 2024 | |||
| NDC Number | Drug Name | Strength | Dosage Form | Package Size | TRICARE RETAIL REFUND |
Formulary Scenarios Condition Set # Formulary Category One of (x) Number of Brand Agents WAC Price of Drug WAC Discount* Total Calculated Retail Refund per Package
| Scenario 1 | 162OCMUN0T2NS1M | Tier 2 | |||
| No Step Therapy | 1 or more | ||||
| 162OCMUN0T3NS1M | Tier 3 | ||||
| No Step Therapy | 1 or more | ||||
| If cell highlights red, please confirm intent not to submit a quote |
Additional Discount Program Appendix – Newly Approved Drug
| #10 | DOD Uniform Formulary Class: | CONTRACEPTIVE AGENTS | P&T Committee Meeting: | November 6-7, 2024 | ||
| DOD Uniform Formulary Subclass: | MULTIPLE | Quotes due: | October 16, 2024 | |||
| NDC Number | Drug Name | Strength | Dosage Form | Package Size | TRICARE RETAIL REFUND |
Formulary Scenarios Condition Set # Formulary Category One of (x) Number of Brand Agents WAC Price of Drug WAC Discount* Total Calculated Retail Refund per Package
| Scenario 1 | 162OCMUN0T2NS1M | Tier 2 | |||
| No Step Therapy | 1 or more | ||||
| 162OCMUN0T3NS1M | Tier 3 | ||||
| No Step Therapy | 1 or more | ||||
| If cell highlights red, please confirm intent not to submit a quote |
File details come from the government source that posted it. Updated .